I am thoroughly up-to-speed on the following competencies... Survey

Compounding beta lactams under FDA’s recent new guidance document

Compounding Thyroid USP in light of FDA’s recent letters to state boards of pharmacy

USP’s newly revised Chapter <795>, regarding non-sterile compounding

USP’s newly revised Chapter <797>, regarding sterile compounding

The rules – and prohibitions – regarding compounding peptides

Best practices for assuring accurate dosing and potency in thyroid compounding

Conducting a gap analysis in my pharmacy

FDA’s Insanitary Conditions Guidance

The 10 tenets of APC’s Compounder Code of Ethics

I am thoroughly up-to-speed on the following competencies...